Trgovina Biotage - BIOT CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 1.9 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.019068% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | -0.003155% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | SEK | ||||||||
Kritje | 20% | ||||||||
Borza | Sweden | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Biotage AB ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Predhodno. Zapri* | 124.3 |
Odpri* | 123.3 |
Enoletna sprememba* | -39.32% |
Dnevni razpon* | 120.7 - 124.5 |
Razpon 52 wk | 115.20-239.40 |
Povprečni obseg (10 dni) | 434.59K |
Povprečni obseg (3 meseci) | 3.20M |
Tržna kapitalizacija | 8.25B |
Razmerje P/E | 30.99 |
Število delnic v obtoku | 65.98M |
Prihodki | 1.57B |
EPS | 4.03 |
Dividenda (donosnost v %) | 1.28 |
Beta | 1.23 |
Datum naslednjega zaslužka | Apr 27, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Mar 23, 2023 | 124.3 | -2.3 | -1.82% | 126.6 | 127.6 | 112.7 |
Mar 22, 2023 | 129.9 | -0.3 | -0.23% | 130.2 | 133.1 | 128.9 |
Mar 21, 2023 | 132.4 | 0.3 | 0.23% | 132.1 | 133.0 | 129.9 |
Mar 20, 2023 | 132.1 | 0.5 | 0.38% | 131.6 | 133.8 | 128.0 |
Mar 17, 2023 | 133.5 | 1.8 | 1.37% | 131.7 | 136.2 | 131.4 |
Mar 16, 2023 | 131.6 | 0.3 | 0.23% | 131.3 | 132.0 | 127.0 |
Mar 15, 2023 | 129.1 | -3.8 | -2.86% | 132.9 | 134.4 | 128.5 |
Mar 14, 2023 | 134.2 | -0.3 | -0.22% | 134.5 | 136.1 | 133.3 |
Mar 13, 2023 | 134.8 | -3.2 | -2.32% | 138.0 | 138.3 | 133.8 |
Mar 10, 2023 | 137.0 | -3.0 | -2.14% | 140.0 | 141.3 | 137.0 |
Mar 9, 2023 | 142.3 | -2.2 | -1.52% | 144.5 | 144.5 | 141.5 |
Mar 8, 2023 | 144.7 | 0.8 | 0.56% | 143.9 | 147.2 | 143.3 |
Mar 7, 2023 | 147.2 | -1.5 | -1.01% | 148.7 | 151.0 | 146.5 |
Mar 6, 2023 | 149.3 | 1.0 | 0.67% | 148.3 | 149.7 | 144.8 |
Mar 3, 2023 | 150.7 | 2.5 | 1.69% | 148.2 | 152.6 | 147.9 |
Mar 2, 2023 | 147.6 | 0.1 | 0.07% | 147.5 | 148.8 | 146.8 |
Mar 1, 2023 | 148.7 | -1.4 | -0.93% | 150.1 | 152.4 | 148.5 |
Feb 28, 2023 | 150.8 | -2.6 | -1.69% | 153.4 | 153.4 | 147.6 |
Feb 27, 2023 | 154.4 | -0.3 | -0.19% | 154.7 | 156.2 | 151.7 |
Feb 24, 2023 | 154.8 | -2.0 | -1.28% | 156.8 | 159.2 | 152.5 |
Biotage Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Skupni prihodki | 1232 | 1092.28 | 1101.37 | 910.896 | 748.147 |
Prihodki | 1232 | 1092.28 | 1101.37 | 910.896 | 748.147 |
Celotni stroški prihodkov | 477 | 425.55 | 415.963 | 354.27 | 291.483 |
Bruto dobiček | 755 | 666.728 | 685.41 | 556.626 | 456.664 |
Celotni odhodki iz poslovanja | 961 | 886.093 | 893.253 | 738.418 | 614.517 |
Celotna prodaja/splošni/upravni stroški Odhodki | 374 | 336.94 | 360.028 | 313.127 | 254.497 |
Raziskave in razvoj | 56 | 44.102 | 49.733 | 43.101 | 33.581 |
Depreciation / Amortization | 65 | 66.449 | 65.132 | 34.032 | 30.241 |
Odhodki (prihodki) od obresti - neto poslovanje | -16 | -19.352 | -2.41 | -14.681 | -8.309 |
Nenavadni odhodki (prihodki) | 2.5 | 2.5 | |||
Other Operating Expenses, Total | 5 | 32.404 | 2.307 | 6.069 | 13.024 |
Prihodki iz poslovanja | 271 | 206.185 | 208.12 | 172.478 | 133.63 |
Prihodki (odhodki) od obresti, neto Neoperativni | -12 | -8.901 | 3.949 | 3.811 | 2.63 |
Drugo, neto | 10 | 25.445 | -0.077 | 0 | 0 |
Čisti dobiček pred obdavčitvijo | 269 | 222.729 | 211.992 | 176.289 | 136.26 |
Čisti dobiček po davkih | 205 | 175.331 | 186.82 | 167.627 | 138.747 |
Čisti dobiček pred dodatnimi postavkami | 205 | 175.331 | 186.82 | 167.627 | 138.747 |
Čisti dobiček | 205 | 175.331 | 186.82 | 167.627 | 138.747 |
Total Adjustments to Net Income | |||||
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 205 | 175.331 | 186.82 | 167.627 | 138.747 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 205 | 175.331 | 186.82 | 167.627 | 138.747 |
Popravljen čisti dobiček | 205 | 175.331 | 186.82 | 167.627 | 138.747 |
Popravljene ponderirane povprečne delnice | 65.4648 | 65.2085 | 65.1821 | 64.7144 | 64.7144 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 3.13145 | 2.68877 | 2.86612 | 2.59026 | 2.14399 |
Dividends per Share - Common Stock Primary Issue | 1.55 | 1.5 | 0 | 1.5 | 1.4 |
Popravljen normalizirani dobiček na enoto čistega dobička | 3.17802 | 2.68877 | 2.89992 | 2.62699 | 2.14399 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Skupni prihodki | 386 | 342 | 305 | 303.458 | 281.35 |
Prihodki | 386 | 342 | 305 | 303.458 | 281.35 |
Celotni stroški prihodkov | 145 | 130 | 122 | 121.281 | 103.889 |
Bruto dobiček | 241 | 212 | 183 | 182.177 | 177.461 |
Celotni odhodki iz poslovanja | 290 | 281 | 237 | 240.943 | 201.972 |
Celotna prodaja/splošni/upravni stroški Odhodki | 122 | 123 | 100 | 94.618 | 86.447 |
Raziskave in razvoj | 25 | 29 | 19 | 23.065 | 19.389 |
Other Operating Expenses, Total | -2 | -1 | -4 | 1.979 | -7.753 |
Prihodki iz poslovanja | 96 | 61 | 68 | 62.515 | 79.378 |
Prihodki (odhodki) od obresti, neto Neoperativni | -4 | 4 | -2 | -1.94 | -2.166 |
Čisti dobiček pred obdavčitvijo | 92 | 65 | 66 | 60.575 | 77.212 |
Čisti dobiček po davkih | 71 | 46 | 53 | 45.973 | 60.039 |
Čisti dobiček pred dodatnimi postavkami | 71 | 46 | 53 | 45.973 | 60.039 |
Čisti dobiček | 71 | 46 | 53 | 45.973 | 60.039 |
Total Adjustments to Net Income | 0.001 | ||||
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 71 | 46 | 53 | 45.973 | 60.04 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 71 | 46 | 53 | 45.973 | 60.04 |
Popravljen čisti dobiček | 71 | 46 | 53 | 45.973 | 60.04 |
Popravljene ponderirane povprečne delnice | 65.9838 | 66.016 | 65.3455 | 65.2674 | 65.2304 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 1.07602 | 0.6968 | 0.81107 | 0.70438 | 0.92043 |
Dividends per Share - Common Stock Primary Issue | 0 | 1.55 | 0 | 0 | 0 |
Popravljen normalizirani dobiček na enoto čistega dobička | 1.07602 | 0.70752 | 0.81353 | 0.72531 | 0.92043 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 774 | 751.615 | 586.569 | 494.438 | 409.252 |
Denarna sredstva in kratkoročne naložbe | 311 | 371.325 | 185.867 | 177.02 | 174.263 |
Denarna sredstva in ustrezniki | 311 | 371.325 | 185.867 | 177.02 | 174.263 |
Celotne terjatve, neto | 207 | 207.455 | 212.815 | 173.728 | 128.939 |
Accounts Receivable - Trade, Net | 180 | 194.018 | 197.651 | 156.042 | 118.191 |
Total Inventory | 237 | 159.823 | 173.76 | 132.338 | 95.794 |
Prepaid Expenses | 19 | 13.013 | 14.128 | 11.352 | 10.256 |
Other Current Assets, Total | -0.001 | -0.001 | |||
Total Assets | 1992 | 1434.44 | 1335.69 | 1003.2 | 757.201 |
Property/Plant/Equipment, Total - Net | 128 | 103.656 | 112.253 | 48.63 | 45.303 |
Property/Plant/Equipment, Total - Gross | 324 | 201.79 | 215.717 | 130.51 | 128.483 |
Accumulated Depreciation, Total | -196 | -98.134 | -103.464 | -81.88 | -83.18 |
Goodwill, Net | 741 | 290.209 | 315.869 | 186.055 | 104.023 |
Intangibles, Net | 313 | 250.787 | 260.047 | 192.654 | 118.646 |
Long Term Investments | 14 | 12.254 | 16.614 | 17.368 | 17.838 |
Note Receivable - Long Term | 0.003 | 0 | |||
Other Long Term Assets, Total | 22 | 25.92 | 44.335 | 64.055 | 62.139 |
Total Current Liabilities | 313 | 217.364 | 212.272 | 173.397 | 144.377 |
Accounts Payable | 56 | 51.236 | 41.461 | 54.764 | 47.457 |
Payable/Accrued | 0.001 | ||||
Accrued Expenses | 58.479 | 69.334 | 60.411 | 50.561 | |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 23 | 21.214 | 21.231 | ||
Other Current Liabilities, Total | 234 | 86.435 | 80.245 | 58.222 | 46.359 |
Total Liabilities | 621 | 444.403 | 460.184 | 301.023 | 148.59 |
Total Long Term Debt | 180 | 140.677 | 147.647 | 109.4 | 0 |
Deferred Income Tax | 73 | 32.838 | 28.884 | 14.78 | 1.621 |
Other Liabilities, Total | 55 | 53.524 | 71.381 | 3.446 | 2.592 |
Total Equity | 1371 | 990.038 | 875.503 | 702.18 | 608.611 |
Common Stock | 92 | 90.969 | 90.63 | 89.953 | 89.953 |
Retained Earnings (Accumulated Deficit) | 1063 | 956.114 | 781.121 | 692.104 | 615.077 |
Other Equity, Total | -50 | -116.547 | 3.752 | -79.877 | -96.419 |
Total Liabilities & Shareholders’ Equity | 1992 | 1434.44 | 1335.69 | 1003.2 | 757.201 |
Total Common Shares Outstanding | 65.9838 | 65.2018 | 64.7144 | 64.7144 | 64.7144 |
Long Term Debt | 150 | 110 | 109.55 | 109.4 | |
Capital Lease Obligations | 30 | 30.677 | 38.097 | ||
Additional Paid-In Capital | 266 | 59.502 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 842 | 774 | 784 | 694.254 | 851.273 |
Denarna sredstva in kratkoročne naložbe | 349 | 311 | 359 | 278.552 | 422.068 |
Denarna sredstva in ustrezniki | 349 | 311 | 359 | 278.552 | 422.068 |
Celotne terjatve, neto | 249 | 226 | 217 | 221.377 | 237.214 |
Accounts Receivable - Trade, Net | 216 | 226 | 181 | 191.724 | 204.607 |
Total Inventory | 244 | 237 | 208 | 194.326 | 191.992 |
Other Current Assets, Total | -0.001 | -0.001 | |||
Total Assets | 2056 | 1992 | 1503 | 1409.61 | 1575.81 |
Property/Plant/Equipment, Total - Net | 126 | 128 | 124 | 125.751 | 126.05 |
Goodwill, Net | 746 | 741 | 304 | 297.524 | 302.381 |
Intangibles, Net | 309 | 313 | 257 | 257.747 | 259.79 |
Long Term Investments | 15 | 14 | 12 | 12.224 | 12.263 |
Other Long Term Assets, Total | 18 | 22 | 22 | 22.115 | 24.051 |
Total Current Liabilities | 298 | 313 | 289 | 263.719 | 246.435 |
Accounts Payable | 43 | 56 | 54 | 46.03 | 53.503 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 23 | 23 | 24 | 23.289 | 22.653 |
Other Current Liabilities, Total | 232 | 234 | 211 | 194.4 | 170.279 |
Total Liabilities | 601 | 621 | 413 | 390.115 | 493.496 |
Total Long Term Debt | 175 | 180 | 37 | 40.861 | 153.626 |
Long Term Debt | 150 | 150 | 0 | 0 | 110 |
Capital Lease Obligations | 25 | 30 | 37 | 40.861 | 43.626 |
Deferred Income Tax | 72 | 73 | 37 | 36.86 | 36.325 |
Other Liabilities, Total | 56 | 55 | 50 | 48.675 | 57.11 |
Total Equity | 1455 | 1371 | 1090 | 1019.5 | 1082.31 |
Common Stock | 92 | 92 | 91 | 90.969 | 90.969 |
Additional Paid-In Capital | 269 | 266 | 64 | 61.239 | 60.137 |
Retained Earnings (Accumulated Deficit) | 1134 | 1063 | 1017 | 964.324 | 1016.15 |
Other Equity, Total | -40 | -50 | -82 | -97.032 | -84.948 |
Total Liabilities & Shareholders’ Equity | 2056 | 1992 | 1503 | 1409.61 | 1575.81 |
Total Common Shares Outstanding | 65.9838 | 65.9838 | 65.2018 | 65.2018 | 65.2018 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | 269 | 222.729 | 211.992 | 176.289 | 136.26 |
Denarna sredstva iz poslovanja | 353 | 279.047 | 211.807 | 155.005 | 168.932 |
Denarna sredstva iz poslovanja | 75 | 73.904 | 74.372 | 39.412 | 34.225 |
Nedenarne postavke | 4 | -11.661 | 2.129 | -11.727 | 1.991 |
Cash Taxes Paid | 16 | 15.083 | 9.925 | 9.314 | 5.091 |
Denarna sredstva Plačane obresti | 3 | 3.339 | 2.86 | 1.738 | 0.002 |
Spremembe v obratnem kapitalu | 5 | -5.925 | -76.686 | -48.969 | -3.544 |
Denarna sredstva pri naložbenju | -341 | -61.32 | -85.676 | -178.411 | -36.903 |
Kapitalski izdatki | -56 | -60.941 | -45.454 | -47.158 | -37.804 |
Celotne druge postavke denarnih tokov pri naložbenju | -285 | -0.379 | -40.222 | -131.253 | 0.901 |
Denarna sredstva pri financiranju | -82 | -22.723 | -119.205 | 19.342 | -81.053 |
Total Cash Dividends Paid | -98 | 0 | -97.803 | -90.6 | -80.893 |
Izdaja (odplačilo) dolga, neto | 16 | -22.723 | -21.402 | 109.942 | -0.16 |
Učinki deviznih tečajev | 9 | -9.547 | 1.921 | 6.821 | -5.336 |
Neto sprememba denarnih sredstev | -61 | 185.457 | 8.847 | 2.757 | 45.64 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 92 | 269 | 204 | 137.787 | 77.212 |
Cash From Operating Activities | 57 | 353 | 249 | 159.904 | 67.62 |
Cash From Operating Activities | 23 | 75 | 54 | 35.656 | 17.133 |
Non-Cash Items | 5 | 4 | -5 | -2.579 | -1.912 |
Cash Taxes Paid | 15 | 16 | 14 | 8.686 | 4.569 |
Changes in Working Capital | -63 | 5 | -4 | -10.96 | -24.813 |
Cash From Investing Activities | -14 | -341 | -45 | -34.637 | -18.266 |
Capital Expenditures | -14 | -56 | -44 | -34.137 | -18.266 |
Other Investing Cash Flow Items, Total | 0 | -285 | -1 | -0.5 | 0 |
Cash From Financing Activities | -6 | -82 | -227 | -223.759 | -5.17 |
Issuance (Retirement) of Debt, Net | -6 | 16 | -129 | -125.956 | -5.17 |
Foreign Exchange Effects | 2 | 9 | 10 | 5.719 | 6.559 |
Net Change in Cash | 39 | -61 | -13 | -92.773 | 50.743 |
Total Cash Dividends Paid | 0 | -98 | -98 | -97.803 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
SEB Investment Management AB | Investment Advisor | 7.55 | 4981775 | -6598 | 2022-12-31 | LOW |
Swedbank Robur Fonder AB | Investment Advisor/Hedge Fund | 6.84 | 4513290 | -1505315 | 2022-12-31 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 5.75 | 3794067 | -41121 | 2022-12-31 | LOW |
ODIN Forvaltning AS | Investment Advisor | 4.5466 | 3000000 | 0 | 2022-12-31 | LOW |
Didner & Gerge Fonder AB | Investment Advisor | 3.8037 | 2509857 | 1528969 | 2022-12-31 | LOW |
Handelsbanken Kapitalförvaltning AB | Investment Advisor/Hedge Fund | 3.6009 | 2375987 | -79811 | 2023-02-28 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.39 | 2236850 | 52787 | 2022-12-31 | LOW |
Lannebo Fonder AB | Investment Advisor/Hedge Fund | 3.3257 | 2194438 | 30000 | 2023-01-31 | LOW |
Tredje AP Fonden | Pension Fund | 3.1 | 2045497 | 310124 | 2022-12-31 | LOW |
Första AP-Fonden | Pension Fund | 2.3926 | 1578713 | 1578713 | 2022-06-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.3377 | 1542486 | 142146 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.86 | 1227298 | 59385 | 2022-12-31 | LOW |
TIN Fonder | Investment Advisor | 1.53 | 1009552 | -10412 | 2022-12-31 | MED |
Montanaro Asset Management Limited | Investment Advisor | 1.37 | 903978 | 219232 | 2022-12-31 | LOW |
M & G Investment Management Ltd. | Investment Advisor | 1.25 | 824797 | 0 | 2022-12-31 | LOW |
Danske Bank Asset Management | Investment Advisor | 1.1684 | 770924 | 181249 | 2023-02-28 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.14 | 752215 | -39590 | 2022-09-30 | LOW |
Goldman Sachs Asset Management, L.P. | Investment Advisor | 1.0636 | 701784 | 0 | 2022-12-31 | LOW |
DNCA Investments | Investment Advisor | 0.9396 | 620000 | -50224 | 2022-12-31 | LOW |
Nordea Funds Oy | Investment Advisor | 0.8978 | 592401 | -4606 | 2023-01-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Biotage Company profile
O družbi Biotage
Biotage AB je podjetje s sedežem na Švedskem, ki razvija in prodaja sisteme, potrošni material in storitve na področju znanosti o življenju. Njene stranke so farmacevtska in biotehnološka podjetja, podjetja v živilski industriji in akademske ustanove. Podjetje ponuja sisteme in storitve na treh področjih: analitična kemija, organska kemija in industrijske smole. Ponudba podjetja Biotage na področju analitične kemije je sestavljena iz potrošnega materiala s povezanimi aplikacijami za ekstrakcijo izbranih snovi iz različnih vrst vzorcev. Družba na področju organske kemije ponuja izdelke za farmacevtski razvoj na osnovi majhnih molekul in peptidov, ponudbo na področju industrijskih smol pa sestavljajo smole na osnovi polimerov in raziskovalne storitve, ki vodijo k razvoju in proizvodnji materialov na osnovi polimerov. Na dan 31. decembra 2013 je družba po vsem svetu upravljala 12 hčerinskih družb v popolni lasti.
Industry: | Medical Diagnostic & Testing Equipment |
Vimpelgatan 5
UPPSALA
UPPSALA 753 18
SE
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com